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Abstract
Background: Infections are the single most important cause of neonatal mortality in developing countries. Results
from trials in Asia evaluating the effect of chlorhexidine on neonatal mortality have been encouraging but limited
data are available on the impact of cord cleansing on bacterial colonization. Further, no data from facility deliveries
and impact with time is available. This pilot study was aimed to evaluate the impact of 4 % commercially prepared
chlorhexidine on cord colonization and density of colonization among newborns in India.
Methods: Three hundred twenty-six newborns (hospital-247; community-79) were enrolled within 24 h of birth and
randomly assigned to one of three groups: chlorhexidine, placebo or dry cord care. Umbilical swabs were collected
at baseline, 2- and 48- hours after intervention application.
Results: At baseline, growth positivity (any bacterial growth) was 20 % (50 of 247 swabs) and 81 % (64 of 79 swabs)
among hospital and community born neonates, respectively. In both settings, chlorhexidine compared to placebo
and dry cord care, reduced colonization following 2- and 48-hour post application. Chlorhexidine significantly
reduced 48-hour post application colony counts in comparison to placebo [Hospital: mean difference = −1.01;
95 % CI: −1.72, −0.30 Community: mean difference = −1.76; 95 % CI: −2.60, −0.93] and dry cord care [Hospital: mean
difference = −1.16; 95 % CI: −1.93, −0.39 Community: mean difference = −2.23; 95 % CI: −3.18, −1.29]. Differences
were similar for gram-positive and gram-negative bacteria.
Conclusions: Cord cleansing with 4 % chlorhexidine soon after birth reduced colonization as well as density of
colonization significantly; however this pilot study does not address the impact of chlorhexidine on mortality. The
control preparation neither increased or decreased colonization.
Trial registration: Clinical Trial Registration: clinicaltrials.gov: NCT01528852, Registered February 7, 2012.
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Background
Neonatal deaths account for 40 % of global under-five
mortality [1–3] and are a major health concern in the
developing countries, particularly in the south Asian and
sub-Saharan countries [4, 5]. Each year serious infections
account for nearly 13 % of the 3 million neonatal deaths,
this proportion is closer to 50 % in settings with high
mortality risk [2]. Five countries namely India, Nigeria,
Democratic Republic of the Congo, Pakistan and China
alone account for half (2.440 million) of the global deaths
from infections and 53.3 % (1.636 million) of neonatal
deaths [5]. Community based studies from developing
world suggest that infections are responsible for 8 to 80 %
of all neonatal deaths and as many as 42 % deaths in first
week of life [5, 6].
In neonates, umbilicus acts as a bacterial reservoir and
a potential entry point for the infection, especially in
first few days of life, when umbilical vein is patent. This
may lead to sepsis with or without omphalitis [7, 8]. The
responsible organisms most likely originate in maternal
genital tract and are acquired during labor and delivery
[9]. In low income countries, many neonatal infections
are environmentally acquired because of higher number
of home deliveries, unsafe traditional practices, untrained
birth attendants and unclean living conditions, all of
which pose an increased risk of umbilical cord infection
[10]. The local signs of umbilical cord infection include
pus, redness, swelling, warmth, tenderness and foul odour
[11] and seem to be associated with increased risk of mor-
tality [12]. Infectious organisms may get directly transmit-
ted from patent umbilical cord to the blood stream
without evident signs of local cord infection [13].
Recommendations for umbilical cord care, particularly
in regard to prevention of umbilical cord infection, are
controversial. In developing countries, World Health
Organization (WHO) [10, 14] promotes dry cord care.
These recommendations were based on lack of evidence
for alternative approaches [14]. Based on currently avail-
able evidence, the WHO recommends 7.1 % chlorhexidine
digluconate solution or gel, (delivering 4 % chlorhexidine)
among home deliveries in settings with neonatal mortality
rate more than 30 [15]. This interim recommendation
awaits review of further data especially the results of two
large trials in Africa.
Of topical antiseptics (eg, ethanol, silver sulfadiazine,
triple dye, gentian violet, chlorhexidine, povidine iodine),
chlorhexidine with strong residual activity has shown
potential as an effective cord care agent during the neo-
natal period against both gram-positive and gram-negative
organisms [16–18]. It has an excellent safety profile, is
rarely associated with bacterial resistance, is easy to admin-
ister and costs few cents per application [9, 19, 20]. Avail-
able high-quality evidence from the recently conducted
Cochrane review indicates that cord cleansing with 4 %
chlorhexidine reduces the risk of neonatal mortality by
12 % and sepsis (omphalitis)/infections by 50 % in low-
resource community settings including Nepal, Bangladesh,
and Pakistan [21]. However, in hospital settings, chlorhexi-
dine cord cleansing reduces the risk of omphalitis/infec-
tions by 52 % and may lead to no difference in neonatal
mortality as compared to dry cord care. Despite all these
data, limited evidence is available on the mechanism of this
protective effect [22–24] and only one study [25] published
recently suggested an impact on bacterial colonization of
the cord and provided information on early neonatal
colonization dynamics in community setting. There are
no data available evaluating impact of chlorhexidine on
colonization among facility births, and spectrum of
chlorhexidine overtime. In all the earlier chlorhexidine
trials evaluating impact on mortality and/or cord infec-
tions, 4.0 % free chlorhexidine were prepared by diluting
20 % chlorhexidine digluconate to the appropriate concen-
tration with purified water at the study sites. As there was
no data available from Africa, two large trials in Africa
(Pemba, Tanzania and Zambia) were funded by Bill and
Melinda gates Foundation to evaluate the mortality impact
of the intervention. In the present pilot study, we tested
the antimicrobial activity of the commercially prepared
4 % chlorhexidine solution as a cord-cleansing agent, and
evaluated its impact on bacterial colonization and colony
counts after 2- and 48-hour post-application in hospital-
and community born neonates in comparison to placebo
(same solution without active ingredients) and dry cord
care. The aim of this pilot study was to ensure and docu-
ment the efficacy of preparation before evaluating mortal-
ity and sepsis impact in large trials (more than 60,000
newborns in African setting). In addition, the pilot study
provided data on potential cord colonizing pathogens




This pilot study was a prospective, randomized, controlled
trial conducted in New Delhi, India. There could be sig-
nificant differences in environmental cleanliness and bac-
teriologic profile in the community and hospital settings;
study subjects from both the settings were included in
order to have a representative sample.
Study population
The hospital component of the pilot study was conducted
at Kalawati Saran Children’s Hospital, New Delhi while
the community component was undertaken at Sangam
Vihar, New Delhi.
Kalawati Saran Children’s Hospital is a government
hospital catering to patients from the lower socio-economic
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strata. Approximately 40–60 deliveries take place daily in
this hospital.
Sangam Vihar is a resettlement colony mainly compris-
ing of migrants from rural areas of the country. Its popula-
tion is predominantly from the low socio-economic strata
of the society. Almost 60 % of the births in Sangam Vihar
take place at home (20–25 deliveries daily).
Training and reliability
Training sessions were organized for the field workers,
supervisors and hospital staff who were apprised of the
study protocol and the various forms that need to be
filled at different time points. Swab sample collection
from the umbilical cord as well as cleaning of cord using
the assigned intervention method was demonstrated using
a dummy doll. This was followed by practice and return
demonstration by trainees on the dummy. Subsequently,
dry run sessions were undertaken by the staff to ensure re-
liability and effective implementation of study protocol.
Recruitment and enrollment
Enrollment in hospital
Study team was stationed outside the maternity ward
from 8.00 am to 5.30 pm. After birth, the study team
comprising of hospital staff and study supervisor visited
the mother baby duo and screened the newborn for eligi-
bility to participate in the study. If the newborn was found
eligible (normal delivery, full term healthy newborns of
both sexes with birth weight >2500 g, first contact ≤48 h),
the study purpose and procedure were explained to the
mother once she was stable or else to the nearest kin and
the consent for their newborn’s participation in the study
was sought. The newborn was enrolled in the study
after the consent was obtained from the parents. Neo-
nates requiring resuscitation and admission to NICU
and also those with major congenital malformation were
excluded.
Enrollment in community
A survey was carried out by trained birth attendants
(TBAs) to identify the pregnant women in the six blocks
of Sangam Vihar. A record of all identified pregnancies
with their tentative due delivery dates was prepared.
The family members and TBAs were instructed to contact
the study supervisor at the time of delivery or immediately
thereafter. The study supervisor and fieldworker along
with the TBA visited the newborn within 48 h of delivery.
They screened the newborn for eligibility (vaginally deliv-
ered, term healthy newborns, first contact ≤48 h) and if
found eligible, the study purpose and procedure were ex-
plained to the mother and the consent for their newborn’s
participation in the study was sought.
Sample size estimations
Based on Nepal hospital data (Hodgins et al [26]) the
sample size was estimated to be 80 in each intervention
group for the hospital setting, with an alpha of 0.05 and
power of 80 %, to detect a reduction in bacterial
colonization from 29 to 11 % in the chlorhexidine group.
Based on Bangladesh study (Mullany et al, personal
communication), the sample size was estimated to be 44
in each intervention group in the community setting,
with an alpha of 0.05 and power of 80 %, to detect a re-
duction in bacterial colonization from 93 to 69 % in the
chlorhexidine group.
Masking and randomization
All enrolled neonates were randomly allocated to 1 of
the 3 intervention groups: (a) 4 % chlorhexidine or (b)
placebo (mild soap water) or (c) dry cord care group.
Both the chlorhexidine and the placebo groups were
blinded and the preparations were identical in pack-
aging, appearance, colour, consistency and odour. It was
not possible to blind the allocation to the dry cord care
group. Each intervention group was identified by a letter
code. The manager in the manufacturing unit decided
the codes to be used for the solutions and kept the infor-
mation secret till the data analysis was complete. Thus,
neither the mothers of the neonates nor the hospital/
field staff knew which intervention was being used. Two
separate randomization lists were prepared; one for the
hospital and other for the community births. For the
hospital, a randomization list containing running serial
number and randomly allocated code (A through I) was
generated. These letter codes were used to identify three
intervention groups. In order to ensure equalization of
groups, six letter codes for the solution (3 codes for
chlorhexidine and 3 for placebo groups) and three letter
codes for the dry cord care were used. In-house computer
software generated a random sequence of group codes
with permuted block length of 18. Neonates were allo-
cated to one of the groups in the order in which they got
enrolled. For the community births, similar randomization
procedure was used.
Intervention description
Intervention was prepared by Galentic Pharma (India)
Pvt. Ltd, Mumbai, India. Table 1 shows the composition
of the chlorhexidine and placebo solution. For the inter-
vention stability, potency, colour, odour and consistency,
the preparations were tested at various stages.
Study procedures
Baseline (0 h) swab collection
For hospital births, soon after delivery, hospital super-
visor checked the hospital records to record birth related
information. Before beginning the procedures, the resident
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doctor washed his/her hands and donned sterile gloves.
The resident doctor on duty collected the swab using
HIMEDIA HiCultureTM transport swabs with amies
medium with charcoal (Cat no: MS 651) from the tip,
stump and base of the umbilicus and peri-umbilical region
(2.5 cm radius around umbilicus) and the hospital super-
visor immediately put the bar-coded sticker on the swab
tube and pasted the corresponding duplicate sticker on
the form. The date and time of the collection of each swab
was recorded on a form. Within 4 h of collection, the
swabs were transferred to the laboratory for culture
analysis. Field/study worker used the same procedure
to collect swabs among the community births.
Application of intervention (immediately following the
collection of swab)
After the collection of swab for culture analysis, hospital
staff/fieldworker applied the assigned intervention im-
mediately. She/he opened the designated intervention
pack and applied the intervention to cleanse the tip,
stump and base of the umbilicus and peri-umbilical re-
gion. The intervention was applied twice: first after the
collection of baseline swab and second 24 h after first
application. In dry cord group, no intervention was ap-
plied and the standard WHO guidelines for cord care
were followed [10].
Swab collection after 2-hours and 48-hours of application
of intervention
In both settings, 2-hours and 48-hours post application,
the study staff collected the umbilical swab, following the
same procedure used for pre-application swab collection.
In case of dry cord, the sample collection and timing was
matched i.e. it was taken 2- and 48- h after the first sample.
Culture analysis
The culture analysis for umbilical cord swabs was per-
formed at Dr Dang’s Medical Diagnostic Center, Hauz
Khas, New Delhi, India. Umbilical swabs collected using
HiCultureTM Transport Swabs (Cat No. MS651) were
transported to laboratory for aerobic culture. All samples
(i.e. 10 μL of the neat specimen) were inoculated in 3
media plates i.e. McConkey Agar, Blood Agar and Choc-
olate Agar. The plates were incubated as per recommended
time and temperature and were checked for absence or
presence of bacterial isolates. Smear was prepared for iden-
tifying gram-negative and gram-positive bacteria. Based on
the morphology and colour of the stain taken by the bac-
teria, they were classified into gram-positive or gram-
negative organisms. Samples were further tested for
species identification using standard manual methods
and Vitek 2 compact system from BioMerieux France.
For colony counts, the samples were put in 1 ml of nor-
mal saline for 3 log dilution and sub-cultured using stand-
ard subculture technique [27]. Presence of bacterial growth,
identification to gram-positive/-negative bacterial or-
ganisms and semi-quantitative colony count was esti-
mated for all samples. Laboratory staff members were
blinded to the formulation used; the swabs and the accom-
panying forms were labeled with bar-coded stickers. In
addition, various quality control measures were followed
using standard American Type Culture Collection strains
during each step and inter/intra observer reliability tests
in microscopy.
Statistical analysis
We used Visual Basic 6.0/ASP.net and Oracle 8i to man-
age the data, with stringent range, consistency, and logical
checks. To ensure data quality and accuracy, real time
data entry was done using netbook. Data were analyzed
separately for the hospital and community births using
Statistical Package of Social Sciences (SPSS Inc., Chicago,
Illinois, USA, SPSS, Version 19.0 for Windows) and Stata
(Stata Corp., College Station, Texas, USA, Intercooled
Stata 12.0 Version), P ≤ 0.05 was considered statistically
significant for all analyses. Descriptive statistics (frequen-
cies, percentages, means and standard deviation) were cal-
culated. We examined the characteristics of newborns and
mothers across the allocated groups on a range of vari-
ables to determine the degree of balance achieved by the
randomization. We analyzed colonization positivity data
by intervention groups and follow-up time. Among those
Table 1 Composition of chlorhexidine and chlorhexidine placebo
Ingredients Chlorhexidine 4 % solution (% v/v) Placebo solution (% v/v)
Chlorhexidine gluconate 20 %w/v solution BP 35.70 -
Polyoxyl 40 hydrogenated castor oil NF (RH 40) 0.80 0.80
Carmoisine 0.0005 0.0005
Purified water BP Q.S to 100.00 Q.S to 100.00
Isopropyl alcohol BP 4.00 -
Mild soap [Sodium lauryl sulphatea (STEROCARE SLS (L))] - 0.40
Silicon antifoaming agenta - 0.001
Note: asodium lauryl sulfate is used to match the foaming which is seen in chlorhexidine 4 % solution and silicon antifoaming agent is used to avoid the excess
foam which forms in the placebo
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that were positive, we further estimated distribution of
colony counts by intervention groups and follow-up time.
A paired analysis comparing the baseline positivity/colony
count of the child with his 2- and 48-hours post interven-
tion positivity/counts was performed to study any group
differences as well as changes over follow-up time within
group. The chi square, t- test and OR with 95 % CI were
used to estimate statistics and significance.
Outcomes
The primary outcome was culture positivity at 2-hours
and 48-hours post application and the secondary out-
come was bacterial colony count from umbilical and
peri-umbilical region to estimate the concentration of vi-
able bacteria. The reduction in bacterial colonization was
assessed as proportion of neonates with positive culture
(from umbilical and peri-umbilical area) 2-hours and 48-
hours after application of 4 % chlorhexidine solution as
compared to dry cord care and control groups. The reduc-
tion in density of bacterial colonization (limited to samples
with growth) after 2-hours and 48-hours of application of
4 % chlorhexidine solution as compared to dry cord care
and control groups was assessed in terms of mean reduc-
tion in bacterial colony counts. The risk of colonization
stratified by gram-positive and gram-negative organisms
was estimated by intervention groups.
Results
Participants
Between November 6, 2010 and December 10, 2010 and
then from January 31, 2011 to February 9, 2011, a total
of 326 newborns both from the hospital (n-247) and
community (n-79) were enrolled in the study. In both
the settings, newborns were randomly assigned to chlor-
hexidine, placebo or dry cord care group and umbilical
swabs were collected at baseline (before the application
of intervention), 2-hour and 48-hour after the application
of the assigned intervention (Fig. 1). Of the 247 neonates
enrolled from the hospital, 48-hour swab sample could not
be collected in 62 neonates (chlorhexidine-23, placebo-22,
dry cord care-17) as the subjects took early discharge from
the hospital and only contributed the first (baseline) and
second (2-hour) swabs. The rate of discharge before the
third swab did not differ between the 3 intervention groups.
A total of 916 umbilical swabs (hospital 679, community
237) were collected. There was no reported adverse event
in the intervention groups in both the settings.
Baseline characteristics
Hospital data
In hospital, among the 247 enrolled neonates, 86 were
allocated to chlorhexidine, 86 to placebo, and 75 to dry
cord care. Comparison of baseline characteristics is shown























Assessed for eligibility (n-=326) 
[Hospital, n=247; Community, n=79]
Excluded (n=0) 
[Hospital, n=0; Community, n=0] 
Randomized (n=326) 
[Hospital, n=247; Community, n=79] 
Allocated to chlorhexidine  
[Hospital, n=86; Community, n=36] 
Allocated to placebo  
[Hospital, n=86; Community, n=24] 
Allocated to dry cord care 
[Hospital, n=75; Community, n=19] 
Loss to follow up* (n=23) 
[Hospital, n=23; Community, n=0] 
Loss to follow up* (n=22) 
[Hospital, n=22; Community, n=0] 
Loss to follow up* (n=17) 
[Hospital, n=17; Community, n=0] 
Analysed (n=122) 
[Hospital, n=86; Community, n=36] 
Analysed (n=110) 
[Hospital, n=86; Community, n=24] 
Analysed (n=94) 
[Hospital, n=75; Community, n=19] 
Fig. 1 Study participants flow diagram
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in Table 2. All groups were comparable as regards the base-
line characteristics such as age of the mother, mode of deliv-
ery, and birth weight of newborns etc. The proportion of
males was higher in groups other than the chlorhexidine
group. Risk factors for infection such as prolonged labor
>24 h, leaking per vagina >24 h, meconium staining, and
maternal urinary tract infection were present but the propor-
tion was very low. The time since birth when the neonate
got enrolled in the study was similar across the three groups.
Community data
Of the 79 neonates enrolled in the community; 36 were
assigned to chlorhexidine, 24 to placebo and 19 to dry
cord care groups. At baseline, no significant differences
were seen in a variety of variables measured, such as age
of the mother, cord cutting methods, hand cleaning be-
fore conducting delivery and babies receiving bath im-
mediately after delivery. The proportion of males was
lower in chlorhexidine group (Table 2).
Bacterial colonization and density of colonization among
positive cultures
Hospital data
At baseline, proportion of positive swabs was 20 % (50
of 247 swabs) among hospital born neonates; it was little
higher in chlorhexidine group (26.7 %) than dry cord care
(18.7 %) and placebo (15.1 %) groups. Chlorhexidine group
showed reduction in colonization in both 2-hours and 48-
hours post application in comparison to baseline. However,
there was an increase in growth positivity rates following 2-
hour and 48-hour post application in dry cord (91.4 %) and
placebo groups (90.6 %). Among those with positive culture
results, colony counts were observed to assess if there was
any intervention impact on density. In the chlorhexidine
group, compared to placebo and dry cord care group, the
mean colony count at the 2-hour and 48-hour follow-up
was lower than the baseline (Table 3) indicating that chlor-
hexidine was effective in reducing the bacterial load.
Table 4 presents the paired comparison between the
groups for bacterial colonization and colony counts.
Comparison of change in growth positivity from baseline
to 2-hours post application showed 80 % reduction with
chlorhexidine application in comparison to placebo
[OR = 0.20; p = 0.001] and 81 % reduction compared to
dry cord care [OR = 0.19; p < 0.001]. There was a 98 %
reduction in change in growth positivity between baseline
and 48-hour post application [chlorhexidine vs. placebo:
OR = 0.02; p < 0.001 and chlorhexidine vs. dry cord:
OR = 0.02; p < 0.001]. Chlorhexidine showed significant
reduction in change in colony counts from baseline to
Table 2 Baseline characteristics and risk factors for infectiona
Variables Chlorhexidine Placebo Dry cord
Hospital data (n = 86) (n = 86) (n = 75)
Age of mother (years, mean ± SD) 23.87 ± 2.54 23.77 ± 2.86 25.12 ± 3.24
Vaginal delivery 100.0 100.0 100.0
Male births 48.8 64.0 58.7
Birth weight (grams, mean ± SD) 2728.3 ± 479.5 2684.3 ± 453.6 2794.8 ± 437.6
No. of pelvic examinations (mean ± SD) 2.37 ± 1.25 2.07 ± 1.00 2.00 ± 0.97
Problems during delivery
Meconium staining 2.3 2.3 5.3
Prolonged labor 2.3 1.2 1.3
Maternal risk factors for infection
LPVb > 24 h 4.7 2.3 2.7
Chorioamnionitis 0.0 0.0 0.0
Fever in mother 1.2 0 1.3
Maternal UTI 0.0 0.0 1.3
Time since birth (hrs:min, mean ± SD) 4:39 ± 2.31 4:35 ± 2:49 4:12 ± 2:37
Community data (n = 36) (n = 24) (n = 19)
Age of mother (years, mean ± SD) 24.42 ± 3.95 24.62 ± 4.13 25.79 ± 3.91
Male births 38.9 50.0 52.6
Did the person clean hands before conducting delivery 97.2 100.0 100.0
New razor blade for cutting the cord 100.0 95.8 100.0
Baby given bath immediately after delivery 94.4 100.0 100.0
aValues are in percentages unless specified
bLPV leaking per vagina
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48-hour post application in comparison to placebo
[difference in mean = −1.01; p = 0.006] and dry cord
[difference in mean = −1.16; p = 0.004].
Community data
Among community births, baseline positivity was 81 %
(64 of 79 swabs) (Table 3). Chlorhexidine showed a non-
significant reduction of 53 % (OR = 0.47; p = 0.17) and a
significant reduction of 86 % (OR = 0.14; p = 0.02) in
change in bacterial colonization from baseline to 2 h
sample as compared to placebo and dry cord care
groups, respectively (Table 4). There was also a signifi-
cant 83 % reduction in change in bacterial colonization
from baseline to 48-hour post application in chlorhexi-
dine group compared to placebo; 90 % compared to dry
cord care. Change in mean colony counts from baseline
to 48-hour post intervention among growth positives
in chlorhexidine group were significantly reduced in
Table 3 Bacterial colonization (proportion with positive culture) and colony counts by intervention group and time of swab collection
Variables Baseline 2-hour post intervention 48-hour post intervention
Hospital data
Bacterial colonizationa,b
Chlorhexidine (n-86, 86, 63) 23 (26.7) 8 (9.3) 12 (19.0)
Placebo (n-86, 86, 64) 13 (15.1) 23 (26.7) 58 (90.6)
Dry Cord (n-75, 75, 58) 14 (18.7) 24 (32.0) 53 (91.4)
Colony counts (Limited to samples with growth)c,d
Chlorhexidine (n-23,8,12) 3.67 ± 1.15 3.01 ± 0.88 3.96 ± 1.69
Placebo (n-13,23,58) 3.71 ± 0.75 3.77 ± 1.06 4.97 ± 0.97
Dry Cord (n-14, 24, 53) 3.88 ± 0.91 3.96 ± 1.69 5.12 ± 1.07
Community Data
Bacterial colonizationa,b
Chlorhexidine (n-36, 36, 36) 30 (83.3) 16 (44.4) 14 (38.9)
Placebo (n-24, 24, 24) 20 (83.3) 15 (62.5) 16 (80.0)
Dry Cord (n-19, 19, 19) 14 (73.7) 14 (73.7) 16 (84.2)
Colony Counts (Limited to samples with growth)c,d
Chlorhexidine (n-30, 16, 14) 5.28 ± 1.00 3.85 ± 1.15 3.32 ± 1.36
Placebo (n-20, 15, 16) 5.25 ± 1.10 5.35 ± 0.77 5.08 ± 0.80
Dry Cord (n-14, 14, 16) 5.85 ± 1.31 5.76 ± 1.24 5.55 ± 0.93
aBacterial colonization was defined as the growth of any organism from the sample; each swab was defined as positive or negative. The total proportion of
neonates positive for any organism was estimated at specific time points i.e. at baseline, 2 and 48 h post intervention and was compared across 3
intervention groups
bValues are expressed in N (%)
cColony counts were estimated among the positive culture swabs at baseline, 2-hour and 48- hour post intervention in three intervention groups to measure the
density of bacterial colonization. The counts were measured in terms of colony-forming units (CFUs) per ml
dValues are expressed in mean ± SD
Table 4 Comparison between chlorhexidine vs. placebo/dry cord care for the bacterial colonization and colony counts
Variables Chlorhexidine vs. placebo Chlorhexidine vs. dry cord
Odds ratio (95 % CI) p value Odds ratio (95 % CI) p value
Hospital
Paired comparison for bacterial colonization between-
Baseline and 2-hour post intervention 0.20 (0.08–0.52) 0.001 0.19 (0.08–0.47) <0.001
Baseline and 48-hour post intervention 0.02 (0.008–0.07) <0.001 0.02 (0.007–0.07) <0.001
Difference in mean of colony counts (95 % CI) at 48 h −1.01 ( −1.72– −0.30) 0.006 −1.16 ( −1.93– −0.39) 0.004
Community
Paired comparison for bacterial colonization between-
Baseline and 2-hour post intervention 0.47 (0.16–1.37) 0.17 0.14 (0.03–0.71) 0.02
Baseline and 48-hour post intervention 0.17 (0.05–0.63) 0.008 0.10 (0.02–0.51) 0.006
Difference in mean of colony counts (95 % CI) at 48 h −1.76 ( −2.60– −0.93) <0.001 −2.23 ( −3.18– −1.29) <0.001
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comparison to placebo [difference in mean = −1.76;
p < 0.001] and dry cord care [difference in mean = −2.23;
p < 0.001].
Specific organisms identified in the hospital and
community setting
Among swabs with positive culture, the presence of
specific organisms was assessed. In the hospital setting,
Acinetobacter spp., Citrobacter diversus, Citrobacter spp.,
Coagulase-negative Staphylococcus, Escherichia coli, Kleb-
siella spp., Pseudomonas aeruginosa, Pseudomonas spp.,
Staphylococcus aureus, Staphylococcus spp. and Viridans
streptococci were the most common organisms, constitut-
ing both gram-positive and gram-negative strains, identi-
fied on the umbilical stump, base and the peri-umbilical
region. However, in the community, Acinetobacter iwoffii.,
Acinetobacter junii, Acinetobacter baumanii, Acinetobacter
haemolyticus, Acinetobacter spp., Acinetobacter ursingii,
Aeromonas hydrophilia, Aeromonas spp., Cedecea davisae,
Citrobacter diversus, Citrobacter spp., Coagulase Negative
Staphylococcus, Escherichia Coli, Enterobacter cloacae,
Klebsiella pneumoniae, Klebsiella spp., Pseudomonas
aeruginosa, Staphylococcus aureus, Staphylococcus len-
tus, and Staphylococcus sciuri were the most common
pathogens identified on the umbilical cord.
When colonization positivity data was analyzed by
gram-positive/gram-negative strains, intervention groups
and follow-up time, the reductions with chlorhexidine
persisted. In hospital born neonates, the overall reduction
in colonization for gram-positive as well as gram-negative
organisms remained significant for the chlorhexidine
group compared to placebo or dry cord care groups for 2-
hours and 48-hours post application samples. For the
community births, there was a significant reduction in
the chlorhexidine group compared to placebo and dry
cord for gram-positive bacteria. For the gram-negative
bacteria, although there was a trend of reduction, the
differences were significant only at 48-hour post appli-
cation (Additional file 1).
Discussion
Chlorhexidine application over umbilical cord has been
shown to reduce the risk of omphalitis and neonatal
mortality in community settings in recent trials done in
Nepal, Pakistan and Bangladesh [21, 28]. In this double
blind randomized controlled trial with facility and commu-
nity data, we evaluated the impact of 4 % chlorhexidine
cord cleansing compared to placebo or dry cord care on
cord colonization. Cord cleansing with 4 % chlorhexidine
showed significant reduction in colonization and density of
pathogens in both facility and community setting. As com-
pared to dry cord care, the impact of 4 % chlorhexidine was
greater in the first 48 h after birth suggesting that chlor-
hexidine may be a possible intervention for reducing
omphalitis and sepsis arising from transmission of bacterial
infections via the umbilical remnant. These findings are in
line with observations reported in a study conducted in
Bangladesh [29, 30].
The potential mechanisms for the chlorhexidine action
in reducing the colonization rates could possibly be the
result of the increased binding efficiency of the detergent
form to the umbilical tissues, resulting in prolonged
residual effect [30]. This bactericidal effect of chlor-
hexidine could be attributed to its chemical structure,
which is a positively charged hydrophobic and lipo-
philic molecule that interacts with phospholipids and
lipopolysaccharides on the cell membrane of bacteria
and enters the cell either through active or passive
transport mechanism [31]. Interaction of the positive
charge of the molecule with the negatively charged
phosphate groups on microbial cell wall [32, 33] alters
the cells’ osmotic equilibrium, increasing the perme-
ability of the cell wall thus allowing the chlorhexidine
molecule to penetrate into the bacteria [34]. Damage
to this delicate membrane is followed by leakage of
intracellular constituents, particularly phosphate entities
such as adenosine triphosphate and nucleic acids. As a
consequence, the cytoplasm becomes congealed, with re-
sultant reduction in leakage; thus, there is a biphasic effect
on membrane permeability. These early changes are bene-
ficial during the critical first few hours and days of life
when most neonatal deaths occur in resource-poor set-
tings [4]. Our data also suggests that mild soap and
water solution (placebo) was not very effective in redu-
cing bacterial colonization in comparison to dry cord
care. This placebo solution only reduced the pathogens
in immediate 2-hours post application swabs in the
community setting and did not produce extended effect
for 48 h. This could be a mere chance finding or cord
cleansing process itself mechanically removed the or-
ganisms from the umbilical and peri-umbilical region,
subsequently decreasing the bacterial load. This indicates
that for residual and cumulative effects, antibacterial
agents such as chlorhexidine are substantially more effect-
ive than non-antiseptic agents [20].
Bacteriologic colonization rates, profile, and dynam-
ics in a community setting might differ substantially
from that in the hospital setting [35]. In the present
study, the observed colonization positivity rate was
higher in the community-setting (81 %) than in the
hospital (20 %) which could be due to unhygienic en-
vironment, unclean delivery practices at homes and
immediate post-delivery traditional practices. Further,
as compared to other studies, the overall pre-
application bacterial growth was low in the hospital
setting which could be due to differences in neonate
handling and infection prevention practices [26, 35,
36]. In the present study, the reported impact of 4 %
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chlorhexidine on the reduction of bacterial colonization
was consistently high in both settings.
This study also describes the specific pathogens col-
onizing the umbilical cord. Trends in colonization
positivity data were assessed by intervention groups,
follow-up time and gram stain status of organisms and
it was observed that chlorhexidine showed high bac-
tericidal activity. The evidence presented here for the
immediate and extended effect of 4 % chlorhexidine
on large and sustained reductions in colonization by
gram-negative and gram-positive organisms due to
early application with chlorhexidine complements the
Cochrane conclusion [14] that colonization is sub-
stantially lower among infants receiving topical
antiseptics compared with those with no specific
treatment (OR = 0.28; 95 % CI: 0.22–0.36).
There were few limitations to our study. The sample
size limited our ability to definitively determine whether
any of the study outcomes could be influenced by one
intervention or the other. But the encouraging findings
in our study were that most of the results were statisti-
cally significant. Our results provide evidence that the
application of 4 % chlorhexidine solution on the umbil-
ical cord provides protection to the baby from bacterial
colonization and growth. The findings of our pilot study
are important but need to be confirmed in a large com-
munity based trial with adequate statistical power as re-
duction in colonization and colony count in small number
of subjects does not have adequate power to evaluate the
impact on mortality or sepsis but does provide data on
possible mechanisms.
The study cannot address an impact that these changes
can have on the microbiome and its implications. From a
comparison study in Pemba and Zambia (personal com-
munication and in submission) it is clear that reduction in
omphalitis may not essentially result in reduction in sepsis
and mortality.
Conclusions
Our study has shown that cord cleaning with the first
time commercially produced 4 % chlorhexidine soon
after birth can significantly reduce colonization as well
as density of colonization among newborns. The study
also demonstrated no impact of the control preparation
compared to dry cord care on colonization (increase or
decrease). The study showed impact of chlorhexidine on
colonization in both hospital and community settings,
but does not speak to relationship between this reduc-
tion and occurrence of sepsis or mortality. The findings
of our pilot study are important but need to be tested in
large community based trials to establish linkage be-
tween reduction in bacterial colonization and sepsis and
or mortality. If the link between reduced colonization
and reduction in neonatal mortality is established in larger
trials in Africa, this intervention could have impact on
neonatal mortality in developing country settings where
there is limited availability of resources, stringent customs
and poor environmental hygiene.
Additional file
Additional file 1: Supplementary Tables (Supplementary Tables 1–3).
(PDF 75 kb)
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